A management strategy for fetal immune-mediated atrioventricular block

References

• Eronen M, Siren MK, Ekblad H, Tikanoja T, Julkunen H, Paavilainent T. Short and long term outcome of children with congenital complete heart block diagnosed in utero or as a newborn. Pediatrics 2000;106:86–91.
   PubMed Web of Science ®Google Scholar
• Groves AM, Allan LD, Rosenthal E. Outcome of isolated congenital complete heart block diagnosed in utero. Heart 1996;75:190–194.
   PubMed Web of Science ®Google Scholar
• Jaeggi ET, Hamilton RM, Silverman ED, Zamora SA, Hornberger LK. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. J Am Coll Cardiol 2002;39:130–137.
   PubMed Web of Science ®Google Scholar
• Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, Lee LA, Provost TT, Reichlin M, Rider L, et al Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998;31:1658–1666.
   PubMed Web of Science ®Google Scholar
• Jaeggi ET, Fouron JC, Silverman ED, Ryan G, Smallhorn J, Hornberger LK. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation 2004;110:1542–1548.
   PubMed Web of Science ®Google Scholar
• Saleeb S, Copel J, Friedman D, Buyon JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block. Arthritis Rheum 1999;42:1335–2345.
   Google Scholar
• Rosenthal E, Gordon PA, Simpson JM, Sharland GK. Letter regarding article by Jaeggi et al “transplacental fetal treatment improves the outcome of prenatally diagnosed complete AV block without structural heart disease”. Circulation 2005;111:e287–e288.
   Web of Science ®Google Scholar
• Lopes LM, Tavares GM, Damiano AP, Lopes MA, Aiello VD, Schultz R, Zugaib M. Perinatal outcome of fetal atrioventricular block: one hundred and sixteen cases from a single institution. Circulation 2008;118:1268–1275.
   PubMed Web of Science ®Google Scholar
• Shinohara K, Miyagawa S, Fujita T, Aono T, Kidoguchi K. Neonatal lupus erythematosis: results of maternal corticosteroid treatment. Obstet Gynecol 1999;93:952–957.
   PubMed Web of Science ®Google Scholar
• Friedman DM, Kim MY, Copel JA, Davis C, Phoon CKL, Glickstein JS, Buyon JP. Utility of cardiac monitoring in fetuses at risk for congenital heart block. The PR interval and dexamethasone evaluation (PRIDE) Prospective Study. Circulation 2008;117:485–493.
   PubMed Web of Science ®Google Scholar
• Glickstein J, Buyon J, Friedman DM. Pulsed Doppler echocardiographic assessment of PR interval. Am J Cardiol 2000;86:236–239.
   PubMed Web of Science ®Google Scholar
• Nield LE, Silverman ED, Taylor GP, Smallhorn JF, Mullen JBM, Silverman NH, Finley JP, Law YM, Human DG, Seaward PG, et al Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis. Circulation 2002;105:843–848.
   PubMed Web of Science ®Google Scholar
• Patel D, Cuneo B, Viesca R, Rassanan J, Leshko J, Huhta J. Digoxin for the treatment of fetal congestive heart failure with sinus rhythm assessed by cardiovascular profile score. J Matern Fetal Neonatal Med 2008;21:477–482.
   PubMed Web of Science ®Google Scholar
• Mivelaz Y, Raboisson MJ, Fournier A, Fouron JC. Reliability of Doppler echocardiographic investigation in the diagnosis of fetuses with first degree atrioventricular block. Ultrasound Obstet Gynecol 2008;32: OP02.01.
   Google Scholar
• Friedman DM, Zevoudakis I, Buyon JP. Perinatal monitoring of fetal well being in the presence of congenital heart block. Am J Perinatol 1998;15:669–673.
   PubMed Web of Science ®Google Scholar
• Schmidt KG, Ulmer HE, Silverman NH, Kleinman C, Copel JA. Perinatal outcome of fetal complete atrioventricular block. JACC 1991;17:1360–1366.
   Google Scholar
• Hu K, Qu Y, Yue Y, Boutjdir M. Functional basis of sinus bradycardia in congenital heart block. Circ Res 2004;94:e32–e38.
   Web of Science ®Google Scholar
• Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994;120:544–551.
   PubMed Web of Science ®Google Scholar
• Imran N, Huhta J, Ovadia M, Niksch A, Leshko J, Cuneo B. Survival and cardiac function in children with isoimmune AV block treated in utero with transplacental dexamethasone. Am J Obstet Gynecol 2007;197:S148.
   Web of Science ®Google Scholar
• Trucco S, Jaeggi E, Cuneo B, Moon-Grady A, Silverman E, Hornberger LK. Use of intravenous gammaglobulin and steroids in the treatment of maternal autoantibody mediated cardiomyopathy. E-PAS2008:634489.8.
   Google Scholar